Rating Change
Stifel analysts reiterated a Buy rating on Hinge Health, Inc. (NYSE:HNGE) on July 27, 2026.
Rating Change Stifel analysts reiterated a Buy rating on Hinge Health, Inc. (NYSE:HNGE) on July 27, 2026. Market Context Hinge Health, Inc.

Stifel analysts reiterated a Buy rating on Hinge Health, Inc. (NYSE:HNGE) on July 27, 2026.
Hinge Health, Inc. operates in the Healthcare sector. The stock currently trades at $75.11 with a market capitalization of $3.9B.
Analyst coverage from Stifel provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Hinge Health, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 27, 2026 | Stifel | Buy | N/A |
| Jul 27, 2026 | Citizens | Market Outperform | N/A |
| Jul 21, 2026 | Canaccord Genuity | Buy | N/A |
| Jul 13, 2026 | Barclays | Overweight | N/A |
| Jul 13, 2026 | Keybanc | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View HNGE Stock Page
A Buy rating from Stifel reflects the analyst's outlook on Hinge Health, Inc. (NYSE:HNGE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HNGE forecast page.
Current market data
NYSE · HNGE
$88.42
Up: +$2.80 · +3.27%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·